The clinically approved drugs amiodarone, dronedarone and verapamil inhibit filovirus cell entry
Author(s) -
Gerrit Gehring,
Katrin Rohrmann,
Nkacheh Atenchong,
Eva Mittler,
Stephan Becker,
Franziska Dahlmann,
Stefan Pöhlmann,
Florian W. R. Vondran,
Sascha David,
Michael P. Manns,
Sandra Ciesek,
Thomas von Hahn
Publication year - 2014
Publication title -
journal of antimicrobial chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.124
H-Index - 194
eISSN - 1460-2091
pISSN - 0305-7453
DOI - 10.1093/jac/dku091
Subject(s) - dronedarone , enfuvirtide , viral entry , amiodarone , pharmacology , entry inhibitor , virology , verapamil , arenavirus , biology , medicine , virus , viral replication , immunology , calcium , lymphocytic choriomeningitis , antigen , gp41 , cd8 , epitope , atrial fibrillation
Filoviruses such as Ebola virus and Marburg virus cause a severe haemorrhagic fever syndrome in humans for which there is no specific treatment. Since filoviruses use a complex route of cell entry that depends on numerous cellular factors, we hypothesized that there may be drugs already approved for human use for other indications that interfere with signal transduction or other cellular processes required for their entry and hence have anti-filoviral properties.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom